THERAPEUTICS ACQUISITION COR (RACA)
Institutional ownership reported to the SEC as of Q2 2021, across 4 quarters.
21
Reporting holders
$197.8M
Reported value
0.0%
Held as options
-7
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| BVF INC/IL | $28.5M | 2,772,226 | 1.07% | 4q | +259.0%+$20.6M |
| BOXER CAPITAL, LLC | $25.7M | 2,500,000 | 0.91% | 4q | +66.7%+$10.3M |
| Farallon Capital Management LLC | $24.7M | 2,400,000 | 0.10% | new | NEW |
| SUVRETTA CAPITAL MANAGEMENT, LLC | $21.0M | 2,045,600 | 0.31% | 2q | +90.1%+$10.0M |
| PERCEPTIVE ADVISORS LLC | $15.4M | 1,500,000 | 0.10% | 4q | HELD |
| BlackRock Inc. | $15.4M | 1,494,816 | 0.00% | 4q | HELD |
| RA CAPITAL MANAGEMENT, L.P. | $11.3M | 1,098,318 | 0.18% | new | NEW |
| SPHERA FUNDS MANAGEMENT LTD. | $10.4M | 1,009,497 | 0.70% | 4q | +40.2%+$3.0M |
| Johnson & Johnson Innovation - JJDC, Inc. | $10.3M | 1,000,000 | 1.05% | new | NEW |
| Fairmount Funds Management LLC | $8.9M | 864,214 | 3.65% | 2q | +1628.4%+$8.4M |
| Alyeska Investment Group, L.P. | $7.5M | 744,200 | 0.09% | new | NEW |
| RTW INVESTMENTS, LP | $5.0M | 490,000 | 0.08% | 4q | HELD |
| CITADEL ADVISORS LLC | $4.8M | 500,000 | 0.00% | 4q | -1.7%-$84.8K |
| BERYLSON CAPITAL PARTNERS, LLC | $4.0M | 386,221 | 0.88% | new | NEW |
| WELLINGTON MANAGEMENT GROUP LLP | $3.5M | 343,410 | 0.00% | 4q | -1.3%-$44.9K |
| D. E. Shaw & Co., Inc. | $681.0K | 66,282 | 0.00% | new | NEW |
| FIRETHORN WEALTH PARTNERS, LLC | $303.0K | 29,485 | 0.25% | new | NEW |
| Sigma Planning Corp | $219.0K | 21,315 | 0.01% | 3q | HELD |
| Claro Advisors LLC | $163.0K | 15,850 | 0.07% | 2q | +2.9%+$4.6K |
| Magnetar Financial LLC | $159.0K | 15,514 | 0.00% | 2q | +19.4%+$25.8K |
| UBS Group AG | $5.0K | 509 | 0.00% | 3q | -88.8%-$39.4K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2021 | 21 | $197.8M | 19,297,457 | 7 | 7 | 3 | 0.0% |
| Q1 2021 | 28 | $148.9M | 14,168,553 | 9 | 5 | 3 | 0.0% |
| Q4 2020 | 25 | $184.5M | 13,239,581 | 5 | 0 | 3 | 0.0% |
| Q3 2020 | 18 | $185.7M | 12,912,506 | 18 | 0 | 0 | 0.0% |